The Babraham Research Campus in Cambridgeshire is to be funded by a £300,000 grant from the East of England Development Agency (EEDA) pilot capital equipment competition. It will give developers access to a drop-in facilities helping to create and bring life-saving drugs to market.
The investment will significantly enhance The Doctors Laboratory’s (TDL) offering to provide a one-stop shop for early-stage ventures in drug discovery and to reduce the need to out-source. It already offers cost-effective services with fully fitted biology and chemistry facilities.
On-site lab experts will provide support sand skills training to those using the cutting-edge equipment, such as micro-array spotters and cell culture fermenters, which might be used for DNA analysis, protein production or antibody development.
EEDA chair Richard Ellis said: ‘It really enabled us to select focal points across the region where we could invest in the infrastructure that ambitious, early-stage bioscience companies need to take them to the next level, and move their concepts closer to market success.’
Through Babraham Biosciences Technologies and the Babraham Research Campus, 52 companies have been supported, and technologies developed at the lab have laid foundations for three new biotech businesses.